Detail of GM0166
Summary
The genetically modified enzybiotic, named pGDC175 , constructed by Mutagenesis strategy, decrease the lytic activity.With pGDC175
Sequence Length: 206 AA.
Mass: 22741.6 Da.
Isoelectric Point: 10.05
Function:
Construction
GM0166, constructed by Mutagenesis strategy. No schema construted on GM0166
Details:
GM0166[1-144]: derive from protein Q6Y7R1 sequence 669-808
Q6Y7R1, 808 AA., the ORF56 from Staphylococcus phage K
Source: Staphylococcus phage K
Linking to UniprotKB
Linging to InterPro
Domains and repeats
674-805: IPR007921, the CHAP domainGO term prediction
No GO info found on GM0166Linking to UniprotKB
Linging to InterPro
GM0166[145-208]: derive from protein P10547 sequence 411-485
P10547, 493 AA., the Lysostaphin from Staphylococcus simulans
Annotation
1-144
145-208
1-144
: EAD, CHAP domain, derived from the phage tailassociated muralytic enzyme of Phage K;145-208
: CBD, SH3b domain, derived from lysostaphin;32
: MUT, mutation with C32S ;Domain and repeats:
145-204
: IPR003646,SH3-like domain, bacterial-type; 6-141
: IPR007921,CHAP domain; GO term prediction:
MSLDSLKKYNGKLPKHDPSFVQPGNRHYKYQSTWYAYNRRGQLGIPVPLWGDAADWIGGAKGAGYGVGRTPKQGACVIWQRGVQGGSPQYGHVAFVEKVLDGGKKIFISEHNYATPNGYGTRTIDMSSAIGKNAQFIYDKK-YKSESASFTPNTDIITRTTGPFRSMPQSGVLKAGQTIHYDEVMKQDGHVWVGYTGNSGQRIYLPV